Each member of the Exelixis management team brings expertise in critical functional areas, including business strategy, finance, sales and marketing, discovery research, clinical development, translational medicine, regulatory affairs and business development. These individuals share a commitment to creating value for stockholders and innovating new therapies that transform the treatment of cancer. Together, they create a dedicated and effective team with the experience and vision to navigate the dynamic biopharmaceutical landscape.
Michael M. Morrissey, Ph.D.
President and Chief Executive Officer
Vice President and Interim Chief Financial Officer
J. Scott Garland
Executive Vice President and Chief Commercial Officer
Jeffrey J. Hessekiel, J.D.
Executive Vice President and General Counsel
Peter Lamb, Ph.D.
Executive Vice President, Discovery Research and Chief Scientific Officer
Gisela M. Schwab, M.D.
Executive Vice President and Chief Medical Officer